FDA approves Bristol Myers Squibb's schizophrenia drug

Bristol Myers Squibb's Cobenfy drug Courtesy: Bristol Myers Squibb The Food and Drug Administration on Thursday approved Bristol-Myers SquibbCobenfy, the…

Novo Nordisk CEO to testify before Senate on weight loss drug prices

Lars Fruergaard Jørgensen, CEO of Novo Nordisk, speaks during an interview in New York on August 10, 2022. Christopher Goodney…

Roche releases more data on slimming pills and injections

Headquarters of Roche, a multinational pharmaceutical industry on December 27, 2021 in Madrid, Spain. Cristina Arias | Cover | Getty…